Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Wheeler

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 29, 2020
Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosisDavid S Wheeler, Keizo Misumi, Natalie M Walker, et al.
Scientific Reports|December 5, 2020
Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axisPengxiu Cao, Natalie M Walker, Russell R Braeuer, et al.
Nitric Oxide : Biology and Chemistry|March 12, 2013
PEX7 and EBP50 target iNOS to the peroxisome in hepatocytesPatricia A Loughran, Donna B Stolz, Stacey R Barrick, et al.
Plos One|January 12, 2018
VEGF may contribute to macrophage recruitment and M2 polarization in the deciduaKaren C Wheeler, Manoj K Jena, Bhola S Pradhan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 4, 2020
Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survivalMichael P Combs, Meng Xia, David S Wheeler, et al.
The Lancet. Respiratory Medicine|January 18, 2021
Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort studyMichael P Combs, David S Wheeler, Jenna E Luth, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 14, 2017
Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?Mahek Shah, Deepakraj Gajanana, David S Wheeler, et al.
JCI Insight|December 3, 2020
Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunctionKeizo Misumi, David S Wheeler, Yoshiro Aoki, et al.
The Journal of Clinical Investigation|September 21, 2021
Transcription factor FOXF1 identifies compartmentally distinct mesenchymal cells with a role in lung allograft fibrogenesisRussell R Braeuer, Natalie M Walker, Keizo Misumi, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic RejectionMichael P Combs, Jenna E Luth, Nicole R Falkowski, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 29, 2020
Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosisDavid S Wheeler, Keizo Misumi, Natalie M Walker, et al.
Scientific Reports|December 5, 2020
Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axisPengxiu Cao, Natalie M Walker, Russell R Braeuer, et al.
Nitric Oxide : Biology and Chemistry|March 12, 2013
PEX7 and EBP50 target iNOS to the peroxisome in hepatocytesPatricia A Loughran, Donna B Stolz, Stacey R Barrick, et al.
Plos One|January 12, 2018
VEGF may contribute to macrophage recruitment and M2 polarization in the deciduaKaren C Wheeler, Manoj K Jena, Bhola S Pradhan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 4, 2020
Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survivalMichael P Combs, Meng Xia, David S Wheeler, et al.
The Lancet. Respiratory Medicine|January 18, 2021
Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort studyMichael P Combs, David S Wheeler, Jenna E Luth, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 14, 2017
Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?Mahek Shah, Deepakraj Gajanana, David S Wheeler, et al.
JCI Insight|December 3, 2020
Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunctionKeizo Misumi, David S Wheeler, Yoshiro Aoki, et al.
The Journal of Clinical Investigation|September 21, 2021
Transcription factor FOXF1 identifies compartmentally distinct mesenchymal cells with a role in lung allograft fibrogenesisRussell R Braeuer, Natalie M Walker, Keizo Misumi, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic RejectionMichael P Combs, Jenna E Luth, Nicole R Falkowski, et al.
Pageof 3